Propanc Biopharma Advances towards GMP Manufacture of PRP for Human Trials

December 4, 2017

Responsive image

MELBOURNE, Australia, Dec. 4, 2017 /PRNewswire/ — Propanc Biopharma Inc. (OTCQB: PPCB) (“Propanc Biopharma” or “the Company”), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as…

Category: Precious Metals